CATALYST DOSSIER · UPDATED 2026-11-09
$ROC
tech · convergence 2 · conviction WATCH
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $ROC?
Quantitative
Revenue (CY2026Q2) : $5.1M (+250.0% YoY)
Net Income (CY2026Q2) : $-816.5K (-240.5% YoY)
Catalysts
Multi-spoke convergence : 9 convergent signals fired: earnings, contract, auto_macro_adp_payrolls, auto_macro_banrep_colombia, auto_macro_bls_employment
Risks
Position-sizing discipline : Conviction WATCH (2 score) — size accordingly; no specific catalyst-fade risk flagged
Bear case
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
AORT via biotech r=+0.98 sympathetic (score 24)
ONCO via biotech r=+0.98 sympathetic (score 20)
HYSR via semis r=+0.96 sympathetic (score 13)
INDI via semis r=+0.96 sympathetic (score 13)
AVEX via industrials r=+0.75 sympathetic (score 23)
RAIL via industrials r=+0.75 sympathetic (score 23)
Signals Firing
earnings contract auto_macro_adp_payrolls auto_macro_banrep_colombia auto_macro_bls_employment auto_macro_durable_goods auto_macro_fx_rates auto_macro_options_gex auto_macro_yield_curve
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-10-06 sec_top_gappers +11.3% +0.0% ✓ hit 2026-10-06 sec_top_moat_emerging +11.3% +0.0% ✓ hit 2026-09-30 sec_clean_gappers +5.0% +1.2% ✓ hit 2026-09-30 sec_top_gappers +5.0% +1.2% ✓ hit 2026-09-30 sec_top_moat_emerging +5.0% +1.2% ✓ hit
Lifetime: 5/5 wins · hit-rate 100.0% on +2% intraday
Sympathy Basket AORT via biotech · score 24 ONCO via biotech · score 20 HYSR via semis · score 13 INDI via semis · score 13 AVEX via industrials · score 23 RAIL via industrials · score 23
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.